Sentynl Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.sentynl.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Copper Histidinate Treatment for Menkes Disease
- Conditions
- Menkes Disease
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Sentynl Therapeutics, Inc.
- Registration Number
- NCT04074512
- Locations
- 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸University of California Davis Medical Center, Sacramento, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
News
No news found